- News Home
10 April 2014 11:44 am ,
Vol. 344 ,
Balkan endemic kidney disease surfaced in the 1950s and for decades defied attempts to finger the cause. It occurred...
The Pyrenean ibex, an impressive mountain goat that lived in the central Pyrenees in Spain, went extinct in 2000. But a...
Tight budgets are forcing NASA to consider turning off one or more planetary science projects that have completed their...
Ebola is not a stranger to West Africa—an outbreak in the 1990s killed chimpanzees and sickened one researcher. But the...
In an as-yet-unpublished report, an international panel of geoscientists has concluded that a pair of deadly...
Tropical disease experts tried and failed before to eradicate yaws, a rare disfiguring disease of poor countries. Now,...
Since 2002, researchers have reported that agricultural communities in the hot and humid Pacific Coast of Central...
- 10 April 2014 11:44 am , Vol. 344 , #6180
- About Us
Stem Cell Case Has 'Immediate and Devastating' Impact, Says Research Group
3 September 2010 5:13 pm
A broad research coalition has formally weighed in on the stem cell case, urging Chief Judge Royce Lamberth to suspend his injunction last week halting human embryonic stem cell research. Lamberth faces a Tuesday deadline to make his decision after the Department of Justice (DOJ) on 31 August asked for an emergency stay. Late this afternoon, with a long weekend looming, the Coalition for the Advancement of Medical Research (CAMR), an advocacy group that includes about 100 patient organizations, scientific societies, and foundations, filed an 11-page amicus brief hoping to tip the judge in that direction.
The CAMR brief focuses on two elements it says need to be considered in evaluating the injunction: the public interest in the case and the stay’s impact on patients. The coalition argues that if the judge’s injunction halting the research stands, “the result would be an immediate and devastating impact on ongoing research,” in part because researchers “will have no way to know when such activities may resume.” Because it already takes so long to transform basic scientific findings into actual treatments, the delay “inevitably will harm patients,” the coalition argues.
See our complete coverage of this issue.